Steve discusses the sustainability challenges and opportunities associated with drug delivery devices, particularly focusing on reusable injectable devices. While reusable injectors are not new, existing for over 15 years, recent trends in the pharmaceutical industry, including the rise of GLP-1 medications and more complex biologic therapies, are driving increased demand for sustainable device solutions. The growing patient population and injection volumes are generating massive waste, emphasizing the need for innovation in both reusable and disposable devices.
‍